In their institutional series, Kim et al. [17] investigated 25 patients with newly diagnosed IDH-wildtype glioblastoma who underwent GTR of contrast-enhancing lesions and strongly fluorescent regions following 5-ALA administration. Here, IDH1 is linked to glioblastoma.